Ramón
García Sanz
Profesor Titular de Universidad
University of Queensland
Brisbane, AustraliaPublicaciones en colaboración con investigadores/as de University of Queensland (3)
2022
-
IBCL-117 ASPEN: Long-Term Follow-Up Results of a Phase 3 Randomized Trial of Zanubrutinib vs Ibrutinib in Patients With Waldenström Macroglobulinemia
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S385
-
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies
Blood Advances
2020
-
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: The ASPEN study
Blood, Vol. 136, Núm. 18, pp. 2038-2050